APA

Lu J., Zhao F., Peng Z., Zhang M., Lin S., Liang B., Zhang B., Liu X., Wang L., Li G., Tian W., Peng Y., He M. & Li X. (20150826). EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. : Oncotarget.

Chicago

Lu Juan, Zhao Fei-Peng, Peng Zengliu, Zhang Meng-Wen, Lin Shao-Xiong, Liang Bi-Jun, Zhang Bao, Liu Xiong, Wang Lu, Li Gang, Tian Wen-Dong, Peng Ying, He Ming-Liang and Li Xiang-Ping. 20150826. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. : Oncotarget.

Harvard

Lu J., Zhao F., Peng Z., Zhang M., Lin S., Liang B., Zhang B., Liu X., Wang L., Li G., Tian W., Peng Y., He M. and Li X. (20150826). EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. : Oncotarget.

MLA

Lu Juan, Zhao Fei-Peng, Peng Zengliu, Zhang Meng-Wen, Lin Shao-Xiong, Liang Bi-Jun, Zhang Bao, Liu Xiong, Wang Lu, Li Gang, Tian Wen-Dong, Peng Ying, He Ming-Liang and Li Xiang-Ping. EZH2 promotes angiogenesis through inhibition of miR-1/Endothelin-1 axis in nasopharyngeal carcinoma. : Oncotarget. 20150826.